Navigation Links
New information points to safer methadone use for treatment of pain and addiction
Date:3/3/2009

New findings may significantly improve the safety of methadone, a drug widely used to treat cancer pain and addiction to heroin and other opioid drugs, according to researchers at Washington University School of Medicine in St. Louis and the University of Washington in Seattle.

The researchers discovered that the body processes methadone differently than previously believed. Those incorrect assumptions about methadone have been making it difficult for physicians to understand how and when the drug is cleared from the body and may be responsible for unintentional under- or overdosing, inadequate pain relief, side effects and even death.

For many years, methadone has been a mainstay in the treatment of opioid addiction. Taken orally, it suppresses withdrawal and reduces cravings. In recent years, doctors have prescribed methadone more frequently as an effective treatment for acute, chronic and cancer pain. Use of the drug for pain treatment rose 1,300 percent between 1997 and 2006. As more methadone was prescribed, however, adverse events increased by approximately 1,800 percent, and fatalities were up more than 400 percent (from 786 to 3,849) between the years 1999 and 2004.

"Unfortunately, increased methadone use for pain has coincided with a significant increase in adverse events and fatalities related to methadone," says principal investigator Evan D. Kharasch, M.D., Ph.D., an anesthesiologist and clinical pharmacologist at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis. "The important message is that guidelines used by clinicians to direct methadone therapy may be incorrect."

Kharasch, the Russell D. and Mary B. Shelden Professor and director of the Division of Clinical and Translational Research in Anesthesiology at the School of Medicine, and his colleagues report the findings in the March issue of the journal Anesthesiology and online in the journal Drug and Alcohol Dependence
'/>"/>

Contact: Jim Dryden
jdryden@wustl.edu
314-286-0110
Washington University School of Medicine
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Global Med Technologies(R), Inc. Places Its Leading Edge Laboratory Information System at the Fontainebleau Hospital
2. Information Parents Need on Vaccines and Their Childs Health
3. United Spinal Association Introduces The Veterans Health Council: Improving Veterans Health through Information and Advocacy
4. Pennsylvania Commission for Women Helps Lancaster Women Access Health Information
5. Patient knowledge of health information influences cancer treatment
6. High Achieving Los Angeles Charter School to Hold Health Fair Offering Free Medical Screening, Treatment and Information to Students and Their Families
7. Shared Health(R) Proves Health Information Exchange (HIE)Success in Tennessee
8. Statewide Health Information Exchange System to Launch in 23 Orange County Emergency Departments
9. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
10. CVS Caremark Issues Statement on Settlement Concerning Disposal of Patient Information at its Retail Stores
11. Patients Gain Protections in Health Information Technology Law

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New information points to safer methadone use for treatment of pain and addiction
New information points to safer methadone use for treatment of pain and addiction
(Date:11/21/2009)...e-USNewswire/ -- DNC Chairman Tim Kaine issued the...in full debate of health insurance reform legislat.../prnh/20080519/DNCLOGO ) ,, "Today, the Senat...ng health insurance reform. By clearing this first...rtunity to debate the health reform bill on the Se...
(Date:11/21/2009)...RNewswire-FirstCall/ -- Test Test Test Test,Test T...est Test Test Test,Test Test Test Test Test Test T...est Test Test Test Test Test Test Test Test Test T...test More test More test More test,More test More ...test More,test More test , , Please ignore., ...
(Date:11/21/2009)... Group merges their practice with that of E. Steve... (PRWEB) November 21, 2009 -- The New Ha...Gibson, Dr. Dean Cloutier, Dr. John Plachtyna and ... practice with that of esteemed colleague Dr. E. S...ted to retire from dentistry in order to concentra...
(Date:11/20/2009)...swire-USNewswire/ -- The United States Conference ...tial changes its health reform bill in order to ke...nscience protection on abortion, protect access to...visions for adequate affordability. ,, The bish...s disappointment" that creates new and unacceptabl...
(Date:11/20/2009)...re-FirstCall/ -- Centene Corporation (NYSE: CN...nk of America Merrill Lynch 2009 Credit Conference...za Hotel Times Square in New York City. ,, Cent....m. Eastern Time. Investors and other interested p...,s presentation at: http://www.veracast.com/webca...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:New Haven Dental Group Expands Their Vision 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
...R) is pleased to,announce a new Small Child Mode f...lume instrument with patent-pending NeuralHarmonic...care providers to measure,bladder volume noninvasi...adderScan(R) BVI 9400 will make its official,debut...
...ndidate at Georgetown University, has been named a...ciety (Bouchet Society). Crawford is in the Tumor...cer Center, part of the Georgetown University Medi...The Society aims to recognize outstanding scholarl...
...nor from American Psychological ...1 Burgerville, a,chain of 39 quick service restau...ington, has been presented with a national Best Pr...mployee health and well-being including a comprehe...
...s designate Blue Distinction Centers,for Complex a...f ongoing efforts,to raise the overall quality of ...Association (BCBSA) is expanding the Blue Distinct...cers across 33,states. With this expansion, more t...
...Manufacturing (GSM),a New Hampshire-based contract...cial markets, acquired Scandia Manufacturing Compa...ion hydraulic and mechanical marine systems,for th...s to maintain all operations at,Scandia,s 22,000 f...
...cialized Pediatric Patient Education at ... WILMINGTON, Del., March 11 ,GetWellNetwork, Inc.,...PC),solutions, and KidsHealth, the largest provide...cifically designed for,parents, kids and teens. Th...
Other Medicine News:Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 3Health News:Georgetown U student selected for prestigious Bouchet Society 2Health News:Burgerville Honored for Dedication to Employees and Innovative Workplace Practices 2Health News:Burgerville Honored for Dedication to Employees and Innovative Workplace Practices 3Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 2Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 3Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 4Health News:Granite State Manufacturing Acquires Scandia Manufacturing Company Inc. 2Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 2Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 3Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 4
(Date:11/20/2009)...-- ,, Reportlinker.com announces that a new mar... ,, Global Markets for Breast Biopsy Devices 2...Global-Markets-for-Breast-Biopsy-Devices-2009.html...ampaign=prnewswire ,, The global markets for ...ore needle market and vacuum assisted breast biops...
(Date:11/20/2009)...tCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ...utive Officer, and Greg Browne, Chief Financial Of...ay Health Care Conference in New York on Wednesday...e session and webcast will be audio only and no fo... host a webcast of the presentation live and by re...
(Date:11/19/2009).../ -- Warner Chilcott plc (Nasdaq: WCRX ) today an...condary offering of 20,000,000 of its ordinary sha... The selling shareholders include funds affiliated... J.P. Morgan Partners (advised by CCMP Capital) an...itutional investors and members of the Company,s s...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Placental precursor stem cells require testosterone free environment to survive 10574 1Placental precursor stem cells require testosterone free environment to survive 10574 2American Physiological Society endorses report on random source dogs and cats 10569 1American Physiological Society endorses report on random source dogs and cats 10569 2American Physiological Society endorses report on random source dogs and cats 10569 3The Breema Center Offers Bodywork Mini Sessions and Demonstrations at the San Francisco Green Festival 60315 1The Breema Center Offers Bodywork Mini Sessions and Demonstrations at the San Francisco Green Festival 60315 2
...t from,Schering-Plough, Roche today affirmed the v...ination with ribavirin as the market-leading,treat...States and globally.,Despite clear biases in the d...d patients taking Peg-Intron(TM) (peginterferon al...reduction protocol - the study results have,shown ...
...ay, SOUTH SAN FRANCISCO, Calif., Jan. 14 Cell,Ge...the Independent Data,Monitoring Committee (IDMC) f...cal trials of GVAX immunotherapy for prostate canc...nd has recommended that the study continue.,This e...mine whether the,study should continue to completi...
Other Medicine Technology:Roche responds to announcement of 'IDEAL' hepatitis C trial results 2Roche responds to announcement of 'IDEAL' hepatitis C trial results 3Roche responds to announcement of 'IDEAL' hepatitis C trial results 4Roche responds to announcement of 'IDEAL' hepatitis C trial results 5Roche responds to announcement of 'IDEAL' hepatitis C trial results 6Roche responds to announcement of 'IDEAL' hepatitis C trial results 7Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 2Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 3Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 4
TeleRehab™ Advantage
ISI DuraHand
ISI Lexan Universal K Table
MagPrep® Streptavidin Beads
Medicine Products: